Cardiovascular (CV)

Global Cardiovascular Clinical Trialists Forum (CVCT) 2025

Congress Details

December 8-10, 2025

Washington, DC

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Congress Materials

Presentation Type

Presentation

Location

Washington, D.C.

Title

Zilebesiran as Add-On Therapy in Patients With Hypertension Who Have Cardiovascular Disease or are at High Cardiovascular Risk: The ZENITH Trial Design